ASTMH Helps Kick Off Global Health Week in Washington

Posted 27 February 2013

Proposed budget cuts to U.S. research and development programs could have a devastating impact on global health research in particular. Specifically, current efforts to develop new tuberculosis drugs, the world's first malaria vaccine, and other vital global health products in development are among the projects that could be in jeopardy, according to a new report from the Global Health Technologies Coalition (GHTC), of which ASTMH is a member.

ASTMH table at the event.

To launch the report and signal the start of "Global Health Week on the Hill," GHTC hosted a panel discussion on Capitol Hill, titled, "Renewing U.S. leadership: Policies to advance global health research."

Two of the three panelists had ASTMH affiliations. Dr. Lee Hall, chief of the Parasitology and International Programs Branch at the National Institute of Allergy and Infectious Diseases, is a member of the Society, and Dr. Alan Magill, director of Malaria at the Bill & Melinda Gates Foundation, is ASTMH's President-Elect.

The full GHTC report is available for review here. GHTC's Breakthroughs blog also provides a useful summary of findings.

Images via our Instagram account

Top right: ASTMH exhibit table at the event; Below: Alan Magill and Lee Hall stand in front of a banner for the event in the Kennedy Caucus Room

GoTropMed